Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Orexo AB
Industry Sector: HealthTechnology
CEO: Nikolaj Sørensen
Number Of Employees: 110
Enterprise Value: $87,036,249
PE Ratio: -2.52
Exchange/Ticker 1: SSE:ORX
Exchange/Ticker 2: N/A
Latest Market Cap: $49,991,491
BioCentury | Jul 3, 2024
Data Byte
Five PDUFA dates on deck for July
Decisions from FDA due on a nasal naloxone and Sprycel competitor, among others
BioCentury | Jan 7, 2023
Management Tracks
Schulman named chair of Alnylam, Bertozzi joins board
Plus: Estigarribia becomes InterVenn CEO and updates from Lyndra, Catalio, Pneumagen and more
BioCentury | Apr 18, 2020
Management Tracks
PTC names Matthew Klein as chief development officer; plus Cardurion, Sangamo, TCR2, Five Prime and more
BioCentury | Dec 4, 2019
Company News
Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more
BioCentury | Nov 27, 2019
Company News
Nov. 27 Company Quick Takes: Orexo, GAIA in second deal for substance abuse digital therapy; plus PDUFA date for Verrica's skin infection candidate and $25M fol
BioCentury | Aug 21, 2019
Company News
Orexo, GAIA to develop digital therapeutic for opioid use disorder
BioCentury | Apr 12, 2019
Product Development
Changing models and minds to improve access to addiction treatment
How companies are changing reimbursement, education to improve access to addiction meds
BioCentury | Apr 5, 2019
Product Development
Reaching addiction patients where they’re at
Ending the opioid crisis may require reaching patients outside the healthcare system
Items per page:
1 - 10 of 225